Citadel Advisors’s NRC Health Common Stock NRC Stock Holding History

Citadel Advisors’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,200	Closed	-$229K	–	13813
2025 Q4	$229K	Buy	+12,200	New	+$184K	﹤0.01%	10740
2025 Q2	–	Sell	-400	Closed	-$5.12K	–	14242
2025 Q1	$5.12K	Sell	400 -200	-33%	-$3.21K	﹤0.01%	13840
2024 Q4	$10.6K	Buy	600 +300	+100%	+$5.69K	﹤0.01%	13596
2024 Q3	$6.86K	Buy	300 +100	+50%	+$2.26K	﹤0.01%	13394
2024 Q2	$4.59K	Buy	+200	New	+$6.17K	﹤0.01%	13466
2023 Q1	–	Sell	-400	Closed	-$14.9K	–	15234
2022 Q4	$14.9K	Buy	+400	New	+$15.5K	﹤0.01%	13364

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors's NRC Position: Q2 2026 in Review

Citadel Advisors opened a new position in NRC Health Common Stock (NRC) in Q2 2026: 64,095 shares worth $1.38M. The stake represents ﹤0.01% of the portfolio and ranks #7412 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NRC as recently as Q4 2025.

Citadel Advisors first reported a position in NRC in Q1 2016 and has held it in 29 quarters since. The position peaked at $3.04M in Q2 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

Citadel Advisors held 64,095 shares of NRC Health Common Stock worth $1.38M as of Q2 2026.
NRC Health Common Stock was a new Citadel Advisors position in Q2 2026.
NRC Health Common Stock made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7412 holding.
Citadel Advisors first reported a position in NRC Health Common Stock in Q1 2016 and has held it in 29 quarters since.
Citadel Advisors's NRC Health Common Stock position peaked at $3.04M in Q2 2024.
123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.